HEADER BLOOD CLOTTING 24-OCT-17 6ESO OBSLTE 06-MAR-19 6ESO 6O1G TITLE FULL LENGTH HUMAN PLASMA KALLIKREIN WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMA KALLIKREIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FLETCHER FACTOR,KININOGENIN,PLASMA PREKALLIKREIN,PKK; COMPND 5 EC: 3.4.21.34 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606 KEYWDS PROTEASE, BLOOD CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR J.R.PARTRIDGE,R.M.CHOY REVDAT 4 08-NOV-23 6ESO 1 OBSLTE REVDAT 3 23-JUN-21 6ESO 1 OBSLTE COMPND HETNAM HETSYN REVDAT 2 06-MAR-19 6ESO 1 OBSLTE REVDAT 1 07-NOV-18 6ESO 0 JRNL AUTH J.R.PARTRIDGE,R.M.CHOY,A.SILVA-GARCIA,C.YU,A.BETZ,U.SINHA, JRNL AUTH 2 Z.LI,B.METCALF,H.SHAM JRNL TITL STRUCTURES OF FULL-LENGTH PLASMA KALLIKREIN BOUND TO HIGHLY JRNL TITL 2 SPECIFIC INHIBITORS DESCRIBE A NEW MODE OF TARGETED JRNL TITL 3 INHIBITION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.13 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 87.6 REMARK 3 NUMBER OF REFLECTIONS : 37739 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.1282 - 5.2914 0.97 2902 162 0.1685 0.1774 REMARK 3 2 5.2914 - 4.2044 0.95 2789 157 0.1521 0.1916 REMARK 3 3 4.2044 - 3.6743 0.95 2772 155 0.1730 0.2465 REMARK 3 4 3.6743 - 3.3389 0.90 2650 148 0.2005 0.2389 REMARK 3 5 3.3389 - 3.0999 0.87 2523 142 0.2201 0.2619 REMARK 3 6 3.0999 - 2.9174 0.86 2511 139 0.2421 0.2513 REMARK 3 7 2.9174 - 2.7714 0.85 2467 139 0.2592 0.3225 REMARK 3 8 2.7714 - 2.6508 0.85 2474 138 0.2591 0.3582 REMARK 3 9 2.6508 - 2.5489 0.85 2457 138 0.2707 0.3169 REMARK 3 10 2.5489 - 2.4610 0.85 2467 137 0.2562 0.3192 REMARK 3 11 2.4610 - 2.3841 0.84 2438 137 0.2561 0.3022 REMARK 3 12 2.3841 - 2.3159 0.84 2450 137 0.2704 0.3288 REMARK 3 13 2.3159 - 2.2550 0.83 2410 135 0.2774 0.3559 REMARK 3 14 2.2550 - 2.2000 0.83 2429 136 0.2977 0.3358 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.080 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.93 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4817 REMARK 3 ANGLE : 1.071 6496 REMARK 3 CHIRALITY : 0.042 712 REMARK 3 PLANARITY : 0.004 826 REMARK 3 DIHEDRAL : 15.270 1744 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -39.4715 -9.9234 24.7391 REMARK 3 T TENSOR REMARK 3 T11: 0.2380 T22: 0.2370 REMARK 3 T33: 0.2547 T12: -0.0011 REMARK 3 T13: 0.0223 T23: -0.0232 REMARK 3 L TENSOR REMARK 3 L11: 0.7074 L22: 1.3105 REMARK 3 L33: 0.2537 L12: 0.2474 REMARK 3 L13: 0.0712 L23: 0.0328 REMARK 3 S TENSOR REMARK 3 S11: 0.0211 S12: -0.0397 S13: 0.1953 REMARK 3 S21: 0.0639 S22: -0.0297 S23: 0.2396 REMARK 3 S31: -0.1459 S32: 0.0302 S33: 0.0060 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6ESO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 5 REMARK 5 OBSOLETION UPON AUTHORS REQUEST, NO KNOWN SUPERSEDING ENTRY REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1200007197. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-APR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.127131 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37739 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.0 REMARK 200 DATA REDUNDANCY : 2.100 REMARK 200 R MERGE (I) : 0.05900 REMARK 200 R SYM (I) : 0.05900 REMARK 200 FOR THE DATA SET : 9.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.42700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2ANW, 2F83 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.5 0.1 M SODIUM REMARK 280 CITRATE 25 % PEG 3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 60.96000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ILE A 2 REMARK 465 LEU A 3 REMARK 465 PHE A 4 REMARK 465 LYS A 5 REMARK 465 GLN A 6 REMARK 465 ALA A 7 REMARK 465 THR A 8 REMARK 465 TYR A 9 REMARK 465 PHE A 10 REMARK 465 ILE A 11 REMARK 465 SER A 12 REMARK 465 LEU A 13 REMARK 465 PHE A 14 REMARK 465 ALA A 15 REMARK 465 THR A 16 REMARK 465 VAL A 17 REMARK 465 SER A 18 REMARK 465 CYS A 19 REMARK 465 GLN A 155 REMARK 465 THR A 156 REMARK 465 PHE A 157 REMARK 465 HIS A 158 REMARK 465 LYS A 159 REMARK 465 ALA A 160 REMARK 465 GLU A 161 REMARK 465 TYR A 162 REMARK 465 ARG A 163 REMARK 465 ASN A 380 REMARK 465 SER A 381 REMARK 465 THR A 385 REMARK 465 LYS A 386 REMARK 465 THR A 387 REMARK 465 SER A 388 REMARK 465 THR A 389 REMARK 465 ARG A 390 REMARK 465 TYR A 565A REMARK 465 LYS A 565B REMARK 465 GLU A 565C REMARK 465 GLY A 565D REMARK 465 ASP A 629 REMARK 465 GLY A 630 REMARK 465 LYS A 631 REMARK 465 ALA A 632 REMARK 465 GLN A 633 REMARK 465 MET A 634 REMARK 465 GLN A 635 REMARK 465 SER A 636 REMARK 465 PRO A 637 REMARK 465 ALA A 638 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS A 201 SG CYS A 284 1.24 REMARK 500 SG CYS A 517 SG CYS A 584 1.34 REMARK 500 ND2 ASN A 127 O4 NAG A 702 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 92 114.44 -164.84 REMARK 500 SER A 212 -86.82 -115.81 REMARK 500 ASP A 213 -122.25 37.16 REMARK 500 GLN A 272 117.05 -162.33 REMARK 500 PRO A 291 44.75 -79.38 REMARK 500 LYS A 341 -76.62 -117.38 REMARK 500 GLU A 343 -8.79 69.46 REMARK 500 LEU A 412 -158.45 -100.42 REMARK 500 THR A 413 -31.34 -35.13 REMARK 500 LEU A 441 90.81 -57.66 REMARK 500 GLN A 442 -136.31 -173.10 REMARK 500 ASP A 443 33.71 -76.21 REMARK 500 LYS A 507 -124.91 63.76 REMARK 500 ASP A 509 73.13 -68.61 REMARK 500 SER A 578 127.41 -38.63 REMARK 500 GLU A 600 -71.13 -77.28 REMARK 500 GLU A 606 38.35 38.74 REMARK 500 GLN A 626 61.84 -108.06 REMARK 500 SER A 627 -168.53 -165.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG A 701 REMARK 610 NAG A 702 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAG A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAG A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7SD A 703 DBREF 6ESO A 1 638 UNP P03952 KLKB1_HUMAN 1 638 SEQRES 1 A 638 MET ILE LEU PHE LYS GLN ALA THR TYR PHE ILE SER LEU SEQRES 2 A 638 PHE ALA THR VAL SER CYS GLY CYS LEU THR GLN LEU TYR SEQRES 3 A 638 GLU ASN ALA PHE PHE ARG GLY GLY ASP VAL ALA SER MET SEQRES 4 A 638 TYR THR PRO ASN ALA GLN TYR CYS GLN MET ARG CYS THR SEQRES 5 A 638 PHE HIS PRO ARG CYS LEU LEU PHE SER PHE LEU PRO ALA SEQRES 6 A 638 SER SER ILE ASN ASP MET GLU LYS ARG PHE GLY CYS PHE SEQRES 7 A 638 LEU LYS ASP SER VAL THR GLY THR LEU PRO LYS VAL HIS SEQRES 8 A 638 ARG THR GLY ALA VAL SER GLY HIS SER LEU LYS GLN CYS SEQRES 9 A 638 GLY HIS GLN ILE SER ALA CYS HIS ARG ASP ILE TYR LYS SEQRES 10 A 638 GLY VAL ASP MET ARG GLY VAL ASN PHE ASN VAL SER LYS SEQRES 11 A 638 VAL SER SER VAL GLU GLU CYS GLN LYS ARG CYS THR ASN SEQRES 12 A 638 ASN ILE ARG CYS GLN PHE PHE SER TYR ALA THR GLN THR SEQRES 13 A 638 PHE HIS LYS ALA GLU TYR ARG ASN ASN CYS LEU LEU LYS SEQRES 14 A 638 TYR SER PRO GLY GLY THR PRO THR ALA ILE LYS VAL LEU SEQRES 15 A 638 SER ASN VAL GLU SER GLY PHE SER LEU LYS PRO CYS ALA SEQRES 16 A 638 LEU SER GLU ILE GLY CYS HIS MET ASN ILE PHE GLN HIS SEQRES 17 A 638 LEU ALA PHE SER ASP VAL ASP VAL ALA ARG VAL LEU THR SEQRES 18 A 638 PRO ASP ALA PHE VAL CYS ARG THR ILE CYS THR TYR HIS SEQRES 19 A 638 PRO ASN CYS LEU PHE PHE THR PHE TYR THR ASN VAL TRP SEQRES 20 A 638 LYS ILE GLU SER GLN ARG ASN VAL CYS LEU LEU LYS THR SEQRES 21 A 638 SER GLU SER GLY THR PRO SER SER SER THR PRO GLN GLU SEQRES 22 A 638 ASN THR ILE SER GLY TYR SER LEU LEU THR CYS LYS ARG SEQRES 23 A 638 THR LEU PRO GLU PRO CYS HIS SER LYS ILE TYR PRO GLY SEQRES 24 A 638 VAL ASP PHE GLY GLY GLU GLU LEU ASN VAL THR PHE VAL SEQRES 25 A 638 LYS GLY VAL ASN VAL CYS GLN GLU THR CYS THR LYS MET SEQRES 26 A 638 ILE ARG CYS GLN PHE PHE THR TYR SER LEU LEU PRO GLU SEQRES 27 A 638 ASP CYS LYS GLU GLU LYS CYS LYS CYS PHE LEU ARG LEU SEQRES 28 A 638 SER MET ASP GLY SER PRO THR ARG ILE ALA TYR GLY THR SEQRES 29 A 638 GLN GLY SER SER GLY TYR SER LEU ARG LEU CYS ASN THR SEQRES 30 A 638 GLY ASP ASN SER VAL CYS THR THR LYS THR SER THR ARG SEQRES 31 A 638 ILE VAL GLY GLY THR ASN SER SER TRP GLY GLU TRP PRO SEQRES 32 A 638 TRP GLN VAL SER LEU GLN VAL LYS LEU THR ALA GLN ARG SEQRES 33 A 638 HIS LEU CYS GLY GLY SER LEU ILE GLY HIS GLN TRP VAL SEQRES 34 A 638 LEU THR ALA ALA HIS CYS PHE ASP GLY LEU PRO LEU GLN SEQRES 35 A 638 ASP VAL TRP ARG ILE TYR SER GLY ILE LEU ASN LEU SER SEQRES 36 A 638 ASP ILE THR LYS ASP THR PRO PHE SER GLN ILE LYS GLU SEQRES 37 A 638 ILE ILE ILE HIS GLN ASN TYR LYS VAL SER GLU GLY ASN SEQRES 38 A 638 HIS ASP ILE ALA LEU ILE LYS LEU GLN ALA PRO LEU ASN SEQRES 39 A 638 TYR THR GLU PHE GLN LYS PRO ILE CYS LEU PRO SER LYS SEQRES 40 A 638 GLY ASP THR SER THR ILE TYR THR ASN CYS TRP VAL THR SEQRES 41 A 638 GLY TRP GLY PHE SER LYS GLU LYS GLY GLU ILE GLN ASN SEQRES 42 A 638 ILE LEU GLN LYS VAL ASN ILE PRO LEU VAL THR ASN GLU SEQRES 43 A 638 GLU CYS GLN LYS ARG TYR GLN ASP TYR LYS ILE THR GLN SEQRES 44 A 638 ARG MET VAL CYS ALA GLY TYR LYS GLU GLY GLY LYS ASP SEQRES 45 A 638 ALA CYS LYS GLY ASP SER GLY GLY PRO LEU VAL CYS LYS SEQRES 46 A 638 HIS ASN GLY MET TRP ARG LEU VAL GLY ILE THR SER TRP SEQRES 47 A 638 GLY GLU GLY CYS ALA ARG ARG GLU GLN PRO GLY VAL TYR SEQRES 48 A 638 THR LYS VAL ALA GLU TYR MET ASP TRP ILE LEU GLU LYS SEQRES 49 A 638 THR GLN SER SER ASP GLY LYS ALA GLN MET GLN SER PRO SEQRES 50 A 638 ALA HET NAG A 701 14 HET NAG A 702 14 HET 7SD A 703 56 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM 7SD N-[(6-AMINO-2,4-DIMETHYLPYRIDIN-3-YL)METHYL]-1-({4- HETNAM 2 7SD [(1H-PYRAZOL-1-YL)METHYL]PHENYL}METHYL)-1H-PYRAZOLE-4- HETNAM 3 7SD CARBOXAMIDE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 4 7SD C23 H25 N7 O FORMUL 5 HOH *24(H2 O) HELIX 1 AA1 ASN A 43 HIS A 54 1 12 HELIX 2 AA2 ASP A 70 ARG A 74 5 5 HELIX 3 AA3 CYS A 104 ILE A 108 5 5 HELIX 4 AA4 SER A 133 ASN A 144 1 12 HELIX 5 AA5 SER A 171 THR A 175 5 5 HELIX 6 AA6 LEU A 191 ALA A 195 5 5 HELIX 7 AA7 ASP A 223 HIS A 234 1 12 HELIX 8 AA8 ILE A 249 ARG A 253 5 5 HELIX 9 AA9 GLY A 314 MET A 325 1 12 HELIX 10 AB1 LEU A 336 CYS A 340 5 5 HELIX 11 AB2 ALA A 432 ASP A 437 5 6 HELIX 12 AB3 ASN A 453 ILE A 457 5 5 HELIX 13 AB4 THR A 544 LYS A 550 1 7 HELIX 14 AB5 TYR A 617 GLN A 626 1 10 SHEET 1 AA1 5 LEU A 25 TYR A 26 0 SHEET 2 AA1 5 VAL A 96 HIS A 99 -1 O SER A 97 N TYR A 26 SHEET 3 AA1 5 LEU A 59 LEU A 63 -1 N PHE A 60 O GLY A 98 SHEET 4 AA1 5 GLY A 76 LYS A 80 -1 O LYS A 80 N LEU A 59 SHEET 5 AA1 5 ASP A 35 TYR A 40 -1 N MET A 39 O CYS A 77 SHEET 1 AA2 2 ALA A 29 PHE A 31 0 SHEET 2 AA2 2 LYS A 89 HIS A 91 -1 O VAL A 90 N PHE A 30 SHEET 1 AA3 5 ILE A 115 ARG A 122 0 SHEET 2 AA3 5 ALA A 178 PHE A 189 -1 O SER A 187 N TYR A 116 SHEET 3 AA3 5 PHE A 149 ALA A 153 -1 N TYR A 152 O GLU A 186 SHEET 4 AA3 5 ASN A 165 TYR A 170 -1 O LEU A 167 N SER A 151 SHEET 5 AA3 5 VAL A 124 LYS A 130 -1 N SER A 129 O CYS A 166 SHEET 1 AA4 5 PHE A 206 ALA A 210 0 SHEET 2 AA4 5 THR A 270 TYR A 279 -1 O THR A 270 N ALA A 210 SHEET 3 AA4 5 PHE A 239 TYR A 243 -1 N PHE A 242 O ILE A 276 SHEET 4 AA4 5 VAL A 255 THR A 260 -1 O LEU A 257 N THR A 241 SHEET 5 AA4 5 VAL A 214 LEU A 220 -1 N VAL A 219 O CYS A 256 SHEET 1 AA5 5 TYR A 297 PRO A 298 0 SHEET 2 AA5 5 GLY A 366 TYR A 370 -1 O SER A 368 N TYR A 297 SHEET 3 AA5 5 PHE A 330 SER A 334 -1 N TYR A 333 O SER A 367 SHEET 4 AA5 5 CYS A 345 LEU A 351 -1 O PHE A 348 N THR A 332 SHEET 5 AA5 5 GLU A 305 VAL A 312 -1 N LEU A 307 O LEU A 349 SHEET 1 AA6 2 ASP A 301 GLY A 303 0 SHEET 2 AA6 2 ARG A 359 ALA A 361 -1 O ARG A 359 N GLY A 303 SHEET 1 AA7 8 THR A 395 ASN A 396 0 SHEET 2 AA7 8 GLN A 536 ASN A 539 -1 O LYS A 537 N THR A 395 SHEET 3 AA7 8 CYS A 517 GLY A 521 -1 N GLY A 521 O GLN A 536 SHEET 4 AA7 8 PRO A 581 HIS A 586 -1 O VAL A 583 N TRP A 518 SHEET 5 AA7 8 MET A 589 TRP A 598 -1 O MET A 589 N HIS A 586 SHEET 6 AA7 8 GLY A 609 LYS A 613 -1 O VAL A 610 N TRP A 598 SHEET 7 AA7 8 MET A 561 ALA A 564 -1 N VAL A 562 O TYR A 611 SHEET 8 AA7 8 LEU A 542 VAL A 543 -1 N VAL A 543 O CYS A 563 SHEET 1 AA8 6 TRP A 445 SER A 449 0 SHEET 2 AA8 6 GLN A 405 LYS A 411 -1 N SER A 407 O TYR A 448 SHEET 3 AA8 6 GLN A 415 GLY A 425 -1 O CYS A 419 N LEU A 408 SHEET 4 AA8 6 TRP A 428 THR A 431 -1 O LEU A 430 N SER A 422 SHEET 5 AA8 6 ALA A 485 LEU A 489 -1 O ALA A 485 N THR A 431 SHEET 6 AA8 6 ILE A 466 ILE A 471 -1 N LYS A 467 O LYS A 488 SSBOND 1 CYS A 21 CYS A 104 1555 1555 2.03 SSBOND 2 CYS A 47 CYS A 77 1555 1555 2.01 SSBOND 3 CYS A 51 CYS A 57 1555 1555 2.05 SSBOND 4 CYS A 111 CYS A 194 1555 1555 2.05 SSBOND 5 CYS A 137 CYS A 166 1555 1555 2.05 SSBOND 6 CYS A 141 CYS A 147 1555 1555 2.05 SSBOND 7 CYS A 227 CYS A 256 1555 1555 2.04 SSBOND 8 CYS A 231 CYS A 237 1555 1555 2.05 SSBOND 9 CYS A 292 CYS A 375 1555 1555 2.05 SSBOND 10 CYS A 318 CYS A 347 1555 1555 2.04 SSBOND 11 CYS A 322 CYS A 328 1555 1555 2.06 SSBOND 12 CYS A 340 CYS A 345 1555 1555 2.03 SSBOND 13 CYS A 383 CYS A 503 1555 1555 2.04 SSBOND 14 CYS A 419 CYS A 435 1555 1555 2.03 SSBOND 15 CYS A 548 CYS A 563 1555 1555 2.03 SSBOND 16 CYS A 574 CYS A 602 1555 1555 2.04 SITE 1 AC1 1 ASN A 396 SITE 1 AC2 1 ASN A 127 SITE 1 AC3 15 HIS A 434 GLY A 480 ASP A 483 TYR A 555 SITE 2 AC3 15 ALA A 573 LYS A 575 SER A 578 THR A 596 SITE 3 AC3 15 SER A 597 TRP A 598 GLY A 599 GLY A 601 SITE 4 AC3 15 CYS A 602 HOH A 814 HOH A 823 CRYST1 55.970 121.920 65.890 90.00 105.79 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017867 0.000000 0.005052 0.00000 SCALE2 0.000000 0.008202 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015772 0.00000